Compounds > olomoucine

olomoucine and Cancer of Prostate

olomoucine has been researched along with Cancer of Prostate in 2 studies

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's2 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Hajdúch, M; Hlobilková, A; Kolár, Z; Lenobel, R; Lukesová, M; Mad'arová, J; Murray, PG; Perera, S; Strnad, M; Vojtesek, B1
Bouchal, J; Hlobilková, A; Knillová, J; Kolár, Z; Strnad, M1

Other Studies

2 other study(ies) available for olomoucine and Cancer of Prostate

ArticleYear
Synthetic inhibitors of CDKs induce different responses in androgen sensitive and androgen insensitive prostatic cancer cell lines.
    Molecular pathology : MP, 2002, Volume: 55, Issue:4

    Topics: Cell Division; Cyclin-Dependent Kinases; Enzyme Inhibitors; Humans; Kinetin; Male; Neoplasm Proteins; Neoplasms, Hormone-Dependent; Prostatic Neoplasms; Purines; Receptors, Androgen; Tumor Cells, Cultured

2002
Synergic effects of the cyclin-dependent kinase (CDK) inhibitor olomoucine and androgen-antagonist bicalutamide on prostatic cancer cell lines.
    Neoplasma, 2004, Volume: 51, Issue:5

    Topics: Androgen Antagonists; Anilides; Cell Line, Tumor; Cell Survival; Cyclin-Dependent Kinases; Enzyme Inhibitors; Humans; Kinetin; Male; Nitriles; Prostatic Neoplasms; Purines; Tosyl Compounds

2004